Ngai Hang Victor Chong - 18 Mar 2024 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Reporting relationship: CHIEF MEDICAL OFFICER
Issuer ticker: CLSD
Reported as of: 18 Mar 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Mar 2024, 17:20:42 UTC
Prior SEC filing: 24 Jun 2024
Next SEC filing: 20 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Mark Ballantyne, Attorney-in-Fact

Key filing fact

Ngai Hang Victor Chong filed Form 4 for Clearside Biomedical, Inc. (CLSD) on 18 Mar 2024.

Key facts

This page summarizes Ngai Hang Victor Chong's Form 4 filing for Clearside Biomedical, Inc. (CLSD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 Mar 2024, 17:20.

Change

Previous filing in this sequence was filed on 24 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLSD transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +450,000
Change %
Price: $0.000000
Shares after: 450,000
Date: 18 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 450,000
Exercise price: $1.56
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One-fourth of the shares underlying this option vest on March 18, 2025 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.